Scott A. Young

Investor Relations Contact at FLEXION THERAPEUTICS, INC.

Health Technology

Profile

Scott A.
Young currently works at Flexion Therapeutics, Inc., as VP-Corporate Communications & Investor Relations from 2018 and Invivyd, Inc., as Head-Investor Relations from 2023.

Scott A. Young active positions

Companies	Position	Start
FLEXION THERAPEUTICS, INC.	Investor Relations Contact	2016-10-31
INVIVYD, INC.	Investor Relations Contact	2023-07-31

All active positions of Scott A. Young

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Scott A. Young's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
INVIVYD, INC.	Health Technology

Private companies	1
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.	Health Technology